Related Experiment Video
Updated: Aug 19, 2025

Author Spotlight: Unveiling the Role of SNF2L in Replication Fork Stability and Genome Duplication
Published on: August 23, 2024
POLQ seals post-replicative ssDNA gaps to maintain genome stability in BRCA-deficient cancer cells
Ondrej Belan1, Marie Sebald2, Marek Adamowicz1
1DSB Repair Metabolism Laboratory, The Francis Crick Institute, London NW1 1AT, UK.
Abstract:
POLQ is a key effector of DSB repair by microhomology-mediated end-joining (MMEJ) and is overexpressed in many cancers. POLQ inhibitors confer synthetic lethality in HR and Shieldin-deficient cancer cells, which has been proposed to reflect a critical dependence on the DSB repair pathway by MMEJ. Whether POLQ also operates independent of MMEJ remains unexplored. Here, we show that POLQ-deficient cells accumulate post-replicative ssDNA gaps upon BRCA1/2 loss or PARP inhibitor treatment. Biochemically, cooperation between POLQ helicase and polymerase activities promotes RPA displacement and ssDNA-gap fill-in, respectively. POLQ is also capable of microhomology-mediated gap skipping (MMGS), which generates deletions during gap repair that resemble the genomic scars prevalent in POLQ overexpressing cancers. Our findings implicate POLQ in mutagenic post-replicative gap sealing, which could drive genome evolution in cancer and whose loss places a critical dependency on HR for gap protection and repair and cellular viability.
Insights
The study reveals that DNA repair protein POLQ, beyond its role in MMEJ, also fills single-stranded DNA gaps, impacting cancer genome evolution. Loss of POLQ creates a dependency on homologous recombination (HR) for cancer cell survival.
Area of Science:
- Genetics
- Molecular Biology
- Cancer Research
Background:
- DNA double-strand break (DSB) repair is crucial for maintaining genomic stability.
- POLQ (polymerase theta) is a key enzyme in microhomology-mediated end-joining (MMEJ) and is overexpressed in various cancers.
- POLQ inhibitors show synthetic lethality in homologous recombination (HR) and Shieldin-deficient cancers, suggesting a dependence on MMEJ.
Purpose of the Study:
- To investigate the functions of POLQ beyond its established role in MMEJ.
- To explore POLQ's involvement in repairing post-replicative single-stranded DNA (ssDNA) gaps.
- To understand the implications of POLQ's activities in cancer genome evolution and therapeutic strategies.
Main Methods:
- Cellular assays examining DNA repair pathways in POLQ-deficient cells.
- Biochemical analyses of POLQ's helicase and polymerase activities.
- Investigation of POLQ's role in microhomology-mediated gap skipping (MMGS).
Main Results:
- POLQ-deficient cells accumulate post-replicative ssDNA gaps when HR is compromised (e.g., BRCA1/2 loss) or PARP inhibitors are used.
- Biochemical studies demonstrate POLQ's ability to displace RPA and fill ssDNA gaps.
- POLQ mediates MMGS, generating deletions similar to those found in POLQ-overexpressing cancers.
Conclusions:
- POLQ plays a significant role in mutagenic post-replicative gap sealing, independent of MMEJ.
- This activity of POLQ can contribute to genome evolution in cancer.
- Loss of POLQ function creates a dependency on HR for cellular viability, offering a potential therapeutic vulnerability.
More Related Videos
Related Concept Videos
Restarting Stalled Replication Forks
Translesion DNA Polymerases
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
Long-patch Base Excision Repair
Homologous Recombination
Fixing Double-strand Breaks
DNA Damage can Stall the Cell Cycle

